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Summary. Down syndrome (DS) is the most common
chromosomal aneuploidy. Although trisomy on
chromosome 21 can display variable phenotypes, there is
a common feature among all DS individuals: the
presence of intellectual disability. This condition is
partially attributed to abnormalities found in the
hippocampus of individuals with DS and in the murine
model for DS, Ts65Dn. To check if all hippocampal
areas were equally affected in 4-5 month adult Ts65Dn
mice, we analysed the morphology of dentate gyrus
granule cells and cornu ammonis pyramidal neurons
using Sholl method on Golgi-Cox impregnated neurons.
Structural plasticity has been analysed using
immunohistochemistry for plasticity molecules followed
by densitometric analysis (Brain Derived Neurotrophic
Factor (BDNF), Polysialylated form of the Neural Cell
Adhesion Molecule (PSA-NCAM) and the Growth
Associated Protein 43 (GAP43)). We observed an
impairment in the dendritic arborisation of granule cells,
but not in the pyramidal neurons in the Ts65Dn mice.
When we analysed the expression of molecules related
to structural plasticity in trisomic mouse hippocampus,
we observed a reduction in the expression of BDNF and
PSA-NCAM, and an increment in the expression of
GAP43. These alterations were restricted to the regions
related to dentate granule cells suggesting an
interrelation. Therefore the impairment in dendritic
arborisation and molecular plasticity is not a general
feature of all Down syndrome principal neurons.
Pharmacological manipulations of the levels of plasticity
molecules could provide a way to restore granule cell
morphology and function.
Key words: PSA-NCAM, BDNF, GAP43, Granule
cells, CA1 pyramidal neurons
Introduction
Down syndrome (DS) is the most common
chromosomal aneuploidy, with an incidence of one in
1000 live births (Roizen and Patterson, 2003). Trisomy
of the chromosome 21 induces a variable phenotype that
may include immune deficiencies, heart defects,
increased risk of leukaemia, and early development of
Alzheimer’s disease. The common feature among all DS
subjects is the presence of intellectual disability reflected
by impairment in learning and memory. Neural
mechanisms underlying this alteration may include
defects in the formation of neuronal networks,
information processing and brain plasticity. 
Several animal models that mimic the alterations in
DS are available. One of the most studied is the Ts65Dn
mouse. This model is segmentally trisomic for a portion
of the mouse chromosome 16 that is orthologous to the
long arm of the human chromosome 21. This segment
contains approximately 140 genes, many of which are
highly conserved between mice and humans (Gardiner et
al., 2003; Sturgeon and Gardiner, 2011; Rueda et al.,
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2012). These mice display a delay in the acquisition of a
number of sensory and motor tasks (Holtzman et al.,
1996; Costa et al., 1999; Martínez-Cué et al., 2013), as
well as defects in learning and in the execution of
memory tasks mediated by the hippocampus (Reeves et
al., 1995; Holtzman et al., 1996; Demas et al., 1998,
1999; Escorihuela et al., 1998; Sago et al., 2000; Hyde et
al., 2001), and deficits in long-term potentiation (LTP)
(Siarey et al., 1997, 1999; Kleschevnikov et al., 2004,
2012). Many of these manifestations may be the
consequence of impairment in structural brain plasticity.
Dendritic atrophy is one of the hallmarks of this
pathology (Dierssen and Ramakers, 2006). Studies using
Golgi techniques have shown dendritic atrophy in the
neocortex of adult and young individuals with DS
(Marin-Padilla, 1976; Takashima et al., 1981; Becker et
al., 1986). Moreover, studies in the Ts65Dn model have
demonstrated, among others, alterations in pyramidal
neurons of the neocortex (Dierssen et al., 2003) and
granule cells of hippocampus (Dang et al., 2014)
suggesting that dendritic atrophy is a common feature in
the brain of DS individuals and Ts65Dn mice.
Brain plasticity may underlie the impairment
observed in dendritic arborisation. Brain plasticity can
be defined as the ability to perform adaptive changes
related to the structure and function of the central
nervous system (Zilles, 1992). Structural plasticity takes
place both during development and adulthood. During
development, brain structural plasticity is a fundamental
element that generates the specificity of connections
present in the mature nervous system, allowing
morphogenetic processes such as cell proliferation, cell
migration, axonal or dendritic growth and remodelling.
This plastic ability diminishes with age, becoming
reduced during adulthood and limited to some specific
regions (Bonfanti, 2006). During adulthood, structural
plasticity is reduced to neurogenesis (in the
subventricular zone and in the subgranular zone of the
dentate gyrus), neuritogenesis and synaptogenesis. These
processes are crucial for learning and adaptability
(Cotman et al., 1998; Gage, 2000). 
One of the cerebral regions where brain structural
plasticity remains specially active during adulthood is
the hippocampus (Leuner and Gould, 2010). In adult
animals, the pyramidal neurons of the CA1 and CA3,
and the granule cells of the dentate gyrus are submitted
to dynamic modifications of their dendritic profiles, and
subjected to synaptic plasticity. The generation of new
neurons persists in the dentate gyrus until old age
(Altman, 1962; Altman and Das, 1965; Seress, 2007)
and the formation of these new neurons implies the
growth of axons and dendrites and the formation of new
synapses. Hippocampal function and structure is clearly
impaired in DS as well as in the Ts65Dn model. 
Regarding neurogenesis, a reduction in cell
proliferation has been observed in the subgranular zone
of the dentate gyrus (Clark et al., 2006; López-Hidalgo
et al., 2016), which leads to a reduction in the number of
granule cells (Insausti et al., 1998; Lorenzi and Reeves,
2006). Moreover, an impairment in spine formation and
maturation has been also observed in cortical pyramidal
neurons in DS individuals (Becker et al., 1986).
Synaptically, the expression of synaptophysin (a
reliable marker for synapses (Masliah et al., 1990;
Eastwood and Harrison, 2001)) in the hippocampus, has
shown that the area occupied by this synaptic protein is
larger in Ts65Dn mice than in controls, suggesting an
increase in the size of the synapses (Kurt et al., 2004;
Belichenko et al., 2007, 2009) Similar results were
observed by our group in the primary somatosensory
cortex (Pérez-Cremades et al., 2010). Our group and
others have observed a reduction in the density of
excitatory contacts in the hippocampus (Belichenko et
al., 2004; Hernández-González et al., 2015) and an
increase in the density of inhibitory ones (Hernández-
González et al., 2015). Other studies have shown a
reduction in number of excitatory contacts in the
temporal cortex (Kurt et al., 2000) and an increment of
inhibitory contacts in the primary somatosensory cortex
(Pérez-Cremades et al., 2010).
Our aim is to correlate the impairment in dendritic
arborisation with alterations in the expression of
molecules involved in structural plasticity. We analysed
the morphology of the dendritic arbour of granule cells
and CA1 pyramidal neurons in adult animals, and the
expression of the molecules related with structural
plasticity: Brain Derived Neurotrophic factor (BDNF),
the polysialylated form of the neural cell adhesion
molecule (PSA-NCAM) and the Growth Associated
Protein 43 (GAP43). 
Materials and methods
Experimental mice were generated by repeated
backcrossing of Ts65Dn females to C57/6Ei 9
C3H/HeSnJ (B6EiC3) F1 hybrid males. The parental
generation was obtained from the research colony of
Jackson Laboratory. Euploid littermates of Ts65Dn mice
served as controls. For this study, we used four- to five-
month-old male mice (18 trisomic mice and 30 euploid
mice). The genotypic characterization was established
by qRT-PCR using SYBR Green PCR master mix
(Applied Biosystems) from genomic DNA extracted
from mice tails by means of the phenol-chloroform
method. The relative amount of each gene was
quantified by the ABI PRISM 7700 (Applied
Biosystems). The genes analysed where APP (3 copies)
and Apo-B (2 copies) as previously described (Liu et al.,
2003). The primers used were: for APP (APP-F 5'-TGT
TCG GCT GTG TGA TCC TGT GAC-3'; APP-R 5'-
AGA AAC GAG CGG CGA AGG GC-3') and for Apo-
B (Apo-B-F 5'-TGC CAG GCT TGT GCT GCT GT-3';
Apo-B-R 5'-GGG TGC TGC CTT TCT CTT GGG G-
3'). All animal experimentation was conducted in
accordance with the Directive 2010/63/EU of the
European Parliament and of the Council of 22
September 2010 on the protection of animals used for
scientific purposes and was approved by the Committee
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on Bioethics of the Universitat de València
(2015/VSC/PEA/00046). Every effort was made to
minimize the number of animals used and their
suffering.
Animals, under pentobarbital overanesthesia, were
transcardially perfused using saline followed by a
solution containing 4% paraformaldehyde in PB (0.1 M,
pH 7.4). Brains (12 trisomic and 20 euploid) were
removed and cryoprotected using 30% sucrose. Fifty
micron sections (6 subseries for each brain) were
obtained using a sliding freezing microtome.
Golgi-Cox impregnation and dendritic arborisation
characterization of CA1 pyramidal neurons and dentate
granule cells
Some of the animals (6 trisomic and 10 euploid)
were transcardially perfused using a solution containing
4% paraformaldehyde in PB (0.1M, pH 7.4). Brains
were removed and processed for morphological
characterization following the Golgi-Cox method. In
brief, the hemispheres were dissected in sections of 3
mm and incubated in an chromating solution containing
5% potassium dichromate and 3% glutaraldehyde for 7
days. After that, samples were impregnated in 1% silver
nitrate for 3 days. 150 micron-thick vibratome sections
were obtained. Sections were placed in dishes,
dehydrated and mounted in EPON resin. For dendritic
arborisation the sections were analysed using the Sholl
method (Sholl, 1953). In order to be analysed, Golgi-
impregnated granule and pyramidal CA1 neurons had to
fulfill the following criteria: (1) the cell must not show
any truncated dendrites, (2) the dendritic arbour of the
cell must show at least a process with a length greater
than 120 μm and (3) the soma must be located at least 30
μm deep from the surface of the section. Granule cells
and CA1 pyramidal neurons adhering to these criteria
were drawn using a camera lucida. The Sholl analysis
consists in the number of intersections of the dendrites
within annuli (20 µm wide) of increasing radius centred
in the soma. We selected only neurons in the same
positions within the dentate gyrus granule cell layer (the
external part of the upper blade in the dorsal
hippocampus), and CA1 (dorsal hippocampus). We
analyzed 25 granule cells and 30 pyramidal CA1
neurons from euploid mice and 20 granule and 22
pyramidal CA1 neurons from trisomic mice. In the case
of CA1 pyramidal neurons we analysed separately the
apical and basal dendrites.
Immunohistochemical procedure
Tissue was processed ‘‘free-floating’’ for
immunohistochemistry as follows. Briefly, sections were
incubated with 10% methanol, 3% H2O2 in phosphate-buffered saline (PBS) for 10 min to block endogenous
peroxidase activity.
After this, sections were treated for 1 h with 5%
normal donkey serum (NDS) (Jackson ImmunoResearch
Laboratories, West Grove, PA, USA) in PBS with 0.2%
Triton- X100 (Sigma-Aldrich, St Louis, MO, USA) and
were incubated overnight at room temperature either in
monoclonal mouse IgG anti-GAP43 (1:1000,
Novocastra, NCL-GAP43), polyclonal rabbit IgG anti-
BDNF (1:100, Santa Cruz Biotech, SC-546),
monoclonal mouse IgM anti-PSA-NCAM (1:700,
Chemicon Int. Inc., Temecula, CA, USA, MAB5324),
monoclonal mouse IgG anti-Gephyrin (1:1000, Synaptic
Systems, 147.011) or polyclonal rabbit igG anti-PSD-95
(1:1000, Cell Signaling, 2507) antibodies. After
washing, sections were incubated for 2 h with donkey
anti-mouse IgM., donkey anti-mouse IgG or donkey
anti-rabbit IgG biotinylated antibodies (1:250; Jackson
ImmunoResearch Laboratories, West Grove, PA, USA),
followed by avidin–biotin–peroxidase complex (ABC;
Vector Laboratories, Peterborough, UK) diluted in PBS,
for 30 min. Color development was achieved by
incubating with 0.05% 3,3-diaminobenzidine tetrahydro-
chloride (Sigma-Aldrich) and 0.033% hydrogen
peroxide in PB for 4 minutes. Finally, sections were
mounted on slides, dried for one day at room
temperature, dehydrated in ascending alcohols and
rinsed in xylene. After this, sections were coverslipped
using Eukitt mounting medium (PANREAC). All studied
sections passed through all procedures simultaneously in
order to minimize any difference from the immuno-
histochemical staining itself. To avoid any bias in the
analysis, all slides were coded prior to analysis and
remained so until the experiment was completed.
The antibodies had been previously tested in their
laboratory of origin; they showed a regional and cellular
immunolabelling in the hippocampus similar to previous
descriptions for these antigens. In order to confirm that
some of the immunostaining was not produced by the
secondary antibodies or by the immunohistochemical
protocol, we omitted primary antibodies or substituted
them by normal donkey serum. These controls resulted
in a complete absence of immunostaining in every case.
Densitometrical analysis of expression for the markers
We have analysed the intensity of the
immunohistochemical staining for GAP43, BDNF and
PSA-NCAM in the different subregions and layers of the
hippocampus (strata oriens, pyramidale, radiatum and
lacunosum-moleculare CA1; strata oriens, pyramidale,
radiatum and lucidum of CA3 and strata moleculare,
granulare and hilus of the dentate gyrus. In order to
analyse the intensity of the immunostaining we used a
previously described methodology (Varea et al., 2007a).
Sections of hippocampus (Bregma between -2.06 and -
2.30 mm) were examined with an Olympus CX41
microscope under bright-field illumination, homo-
geneously lit and digitalized using a CCD camera.
Photographs were taken at 200X magnification. Images
were converted to greyscale. Grey levels were measured
using Image J software (NIH). This software can
measure the intensity of expression as a increased grey
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level. Five measurements were taken for each analysed
area. Means were determined for each experimental
group (Ts65Dn vs. euploid littermates) and data were
subjected to one-way ANOVA followed by Student-
Newman-Keuls post hoc tests using the SPSS software
package (version 15). Nissl-stained sections adjacent to
the measured ones were used to determine the location
and borders of the different subregions of the
hippocampus.
Results
Dendritic complexity of granule and pyramidal CA1
neurons
We have analysed the dendritic arborisation of
Golgi-Cox impregnated granule cells (Fig. 1) and
pyramidal CA1 neurons (Fig. 2) using the Sholl method.
This method gives an estimation of the complexity of the
dendritic arbours. The study of granule cells in euploid
and trisomic mice (Fig. 1A,B) revealed a reduction in
the total number of intersections (Fig. 1C). The analysis
along the dendritic arbour revealed that the reduction is
statistically significant in the region between 120 to 160
μm from the cell body (Fig. 1D).
The analysis of dendritic branching of pyramidal
CA1 neurons reflected that there was no alteration in the
complexity of dendrites in trisomic mice when compared
with euploid (Fig. 2A,B). Basal (Fig. 2C,D) and apical
(Fig. 2E,F) dendrites showed similar complexity in
trisomic and euploid mice.
The difference between granule and pyramidal
neurons may be related with alterations in the molecular
environment. This could be the result of the different
expression of molecules related to neuronal structural
plasticity. In order to check this hypothesis we analysed
the expression of these molecules (BDNF, PSA-NCAM
and GAP43) in the hippocampus of control and trisomic
adult mice.
Brain Derived Neurotrophic Factor (BDNF)
The expression of BDNF (Fig. 3) showed a light,
diffuse and homogenous staining, as is expected by the
nature of this factor, being more intense in the strata
pyramidale and oriens of CA1 and the subgranular zone
of the dentate gyrus (Fig. 3A).
We have analysed the expression of BDNF using
densitometry in adult animals comparing control and
trisomic mice (Fig. 3B-J). In the CA1 (Fig. 3B-D) there
were no differences between control and trisomic mice
(normalized optical density 45.3±2.0 vs 47.9±2.6 in the
stratum oriens, 18.9±1.3 vs. 20.4±1.8 in the stratum
pyramidale, 39.5±2.8 vs. 40.1±1.7 in the stratum
radiatum and finally 20.5±1.5 vs. 20.7±2.3 in the stratum
lacunosum-moleculare). In the CA3 (Fig. 3E-G), we
only observed a reduction in the stratum lucidum
(16.3±1.1 vs. 12.1±1.6, p<0.05) of trisomic mice, with
no differences in the other strata (16.9±0.7 vs. 17.6±1.0
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Fig. 1. Alterations in the dendritic branching of hippocampal granule
cells of Ts65Dn mice using Sholl analysis. A, B. Representative camera
lucida drawings from granule cells of euploid and trisomic mice
respectively. C. Graph showing the total number of intersections in
euploid (black bar) and trisomic mice (white bar). D. Number or
intersections at different distances from the cell somata. (* p<0.05).
Scale bar: 50 µm.
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Fig. 2. Alterations in the dendritic branching of hippocampal CA1 pyramidal neurons of Ts65Dn mice using Sholl analysis. A, B. Representative camera
lucida drawings from CA1 pyramidal neurons of euploid and trisomic mice respectively. C. Graph showing the total number of intersections for the basal
dendrites in euploid (black bar) and trisomic mice (white bar). D. Number or intersections of basal dendrites at different distances from the cell somata.
E. Graph showing the total number of intersections for the apical dendrites in euploid (black bar) and trisomic mice (white bar). F. Number or
intersections of apical dendrites at different distances from the cell somata. Scale bar: 50 µm.
in the stratum oriens, 10.1±0.6 vs. 12.2±1.5 in the
stratum pyramidale and 9.5±0.6 vs. 9.1±0.6 in the
stratum radiatum). In the dentate gyrus (Fig. 3H-J), we
observed a statistically significant reduction in the
stratum moleculare and hilus (17.9±1.1 vs.13.3±1.1,
p<0.05 in the stratum moleculare; 17.6±1.1 vs. 14.6±1.9
in the stratum granulare; and 16.9±1.0 vs. 12.8±1.4,
p<0.05 in the hilus).
Polysialylated form of the neural cell adhesion molecule
(PSA-NCAM)
PSA-NCAM in the hippocampus displayed a high
intensity of expression (Fig. 4). We have observed the
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Fig. 3. Alterations in the expression of BDNF in the hippocampus of the Ts65Dn mice. A. Panoramic view of the distribution of BDNF in the
hippocampus. B, E, H. Graphs showing the intensity of expression of BDNF in the different subregions of the hippocampus in euploid mice (black bar)
and trisomic mice (white bar). CA1 (B), CA3 (E), dentate gyrus (H). Representative images of the distribution of BDNF in the hippocampus in euploid
and Ts65Dn mice respectively, CA1 (C-D), CA3 (F-G) and DG (I-J). (* p<0.05). Scale bars: A, 500 µm; C, D, 200 µm; F, G, I, J, 100 µm.
highest intensity in the dentate gyrus and stratum
lucidum of CA3 (newly generated neurons transiently
express PSA-NCAM), followed by a slightly weaker
immunoreactivity in the stratum lacunosum of CA1 (Fig.
4A). The staining showed a punctate distribution due to
its location in the membrane. Moreover, positive cells
could be observed both in the subgranular zone of the
dentate gyrus (corresponding to immature granule cells)
and in other regions of the hippocampus (corresponding
to inhibitory neurons). The analysis of the expression of
PSA-NCAM revealed that in trisomic animals there was
a general decrease in the CA1 (Fig. 4B-D), although it
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Fig. 4. Alterations in the expression of PSA-NCAM in the hippocampus of the Ts65Dn mice. A. Panoramic view of the distribution of PSA-NCAM in the
hippocampus. B, E, H. Graphs showing the intensity of expression of PSA-NCAM in the different subregions of the hippocampus in euploid mice (black
bar) and trisomic mice (white bar). CA1 (B), CA3 (E), dentate gyrus (H). Representative images of the distribution of PSA-NCAM in the hippocampus in
euploid and Ts65Dn mice respectively, CA1 (C-D), CA3 (F-G) and DG (I-J). (* p<0.05). Scale bars: A, 500 µm; C, D, 200 µm; F, G, I, J, 100 µm.
was only statistically significant for the stratum
pyramidale (22.1±2.5 vs. 15.5±1.3 in the stratum oriens;
29.7±2.2 vs. 20.2±1.7, p<0.05 in the stratum pyramidale;
20.4±2.0 vs. 14.7±2.3 in the stratum radiatum and
45.9±3.9 vs. 34.6±4.6 in the stratum lacunosum-
moleculare). In the CA3 (Fig. 4E-G) we also observed a
significant decrease in the expression of PSA-NCAM in
the strata radiatum and lucidum (21.9±2.4 vs. 20.7±1.2
in the stratum oriens; 30.2±2.7 vs. 26.3±1.2 in the
stratum pyramidale; 55.9±2.1 vs. 47.5±1.1, p<0.05 in the
stratum radiatum and 70.7±3.6 vs. 56.4±4.3 p<0.05 in
the stratum lucidum). In the dentate gyrus (Fig. 4H-J) we
have observed a reduced expression of PSA-NCAM in
the hilus (54.8±4.2 vs. 47.1±1.6 in the stratum
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Fig. 5. Alterations in the expression of GAP43 in the hippocampus of the Ts65Dn mice. A. Panoramic view of the distribution of GAP43 in the
hippocampus. B, E, H. Graphs showing the intensity of expression of GAP43 in the different subregions of the hippocampus in euploid mice (black bar)
and trisomic mice (white bar). CA1 (B), CA3 (E), dentate gyrus (H). Representative images of the distribution of GAP43 in the hippocampus in euploid
and Ts65Dn mice respectively, CA1 (C-D), CA3 (F-G) and DG (I-J). (* p<0.05, ** p<0.01). Scale bars: A, 500 µm; C, D, 200 µm; F, G, I, J, 100 µm.
moleculare; 41.8±4.1 vs. 31.0±5.8 in the stratum
granulare and 115.5±3.3 vs. 102.9±1.4 p<0.05 in the
hilus).
Growth associated protein 43 (GAP43)
GAP43 displayed a pattern of staining more intense
than BDNF and presented a punctate appearance (Fig.
5). The highest intensity was observed in the strata
lacunosum-moleculare of CA1 and molecular of the
dentate gyrus. The subgranular zone of the dentate gyrus
also displayed a high intensity of staining (Fig. 5A). The
analysis of the expression of GAP43 revealed a general
increase in intensity in trisomic mice. In the CA1 (Fig.
5B-D), we observed an increased expression in the strata
oriens and lacunosum-moleculare of trisomic mice
(46.4±1.9 vs. 55.5±4.9 p<0.05 in the stratum oriens;
22.8±1.9 vs. 29.5±5.0 in the stratum pyramidale;
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Fig. 6. Alteration in the expression of
postsynaptic markers in the hippocampus of
the Ts65Dn mice. Graph showing the intensity
of expression of PSD-95 (A) and Gephyrin (B)
in the different subregions of the hippocampus
(* p<0.05).
46.1±2.0 vs. 54.2±5.9 in the stratum radiatum and
84.58±2.05 vs. 94.36±5.52 p<0.05 in the stratum
lacunosum-moleculare). In the CA3 (Fig. 5E-G) we
observed no differences between control and trisomic
mice in GAP43 expression (44.3±1.3 vs.49.1±4.5 in the
stratum oriens; 32.6±1.6 vs. 33.5±3.8 in the stratum
pyramidale; 34.1±1.5 vs. 38.3±3.9 in the stratum
radiatum and 85.6±2.0 vs. 94.4±5.5 in the stratum
lucidum). Finally, in the dentate gyrus (Fig. 5H-J), we
observed a significant increase in the expression of
GAP43 in the stratum granulare and the hilus (64.1±1.7
vs. 69.5±3.6 in the stratum moleculare; 50.4±1.7 vs.
60.3±3.1 p<0.01 in the stratum granulare; and 47.4±1.6
vs. 55.9±3.4 p<0.05 in the hilus). Since the inner
molecular layer presents a high expression of GAP43
whereas the outer molecular layer displays a weak
staining, we analysed separately the inner and the outer
molecular layer. The study revealed that the inner
molecular layer of trisomic mice presented a statistically
significant increase in the expression of GAP43 (outer
molecular layer 44.3±2.7 vs. 51.3±1.9; inner molecular
layer 72.5±2.7 vs. 82.4±2.6 p<0.05).
Markers of postsynaptic excitatory and inhibitory
densities
In order to correlate the differences in morphology
and plasticity markers with alterations in the density of
synaptic contacts, we have analysed the expression of
markers for the postsynaptic densities for both,
excitatory (using PSD-95) and inhibitory (using
gephyirin) synaptic contacts. This study complements a
previous study where we analysed the expression of
synaptic markers (presynaptic) (Hernández et al., 2015).
We observed that the optic density of PSD-95 was
not different in trisomic mice in all the regions (Fig. 6A).
However the analysis of gephyrin reflected an increase
of inhibitory contacts in the hippocampus of trisomic
mice in most regions (Fig. 6B).
Discussion
In this report, we have analysed the alterations of
granule cells and CA1 pyramidal neurons in the
hippocampus of the trisomic murine model for Down
Syndrome Ts65Dn. We have observed impairment in the
dendritic arbour in granule cells whereas pyramidal CA1
neurons remained unaltered. We have related this
alteration with the expression of diverse molecules
related to structural plasticity in the hippocampus. The
impairment of the dentate granule cell morphology was
coupled to a reduction in the expression of BDNF and
PSA-NCAM and an increase in the expression of
GAP43 only in the dentate gyrus. 
Dendritic alteration in the principal neurons of the
hippocampus
We have observed an impairment in the dendritic
complexity of granule cells. This is similar to other
similar impairments previously reported in different
brain regions of the Ts65Dn brain (Dierssen et al., 2003;
Dang et al., 2014). Similar results have been obtained in
individuals with DS (Marin-Padilla, 1976; Becker et al.,
1986; Ferrer and Gullotta, 1990). The impairment in
granule cell arborisation observed is similar to those
observed in 5-6 month old Ts65Dn mice (Dang et al.,
2014). Dendritic arborisation of granule neurons is
located in the stratum moleculare, where the projections
from the entorhinal cortex through the perforant pathway
arrives. This constitutes the main input of information
into the hippocampus. It has been pointed out that
dendritic impairment is a general feature of DS
(Dierssen and Ramakers, 2006), however, the study of
the complexity of the dendritic arbour in CA1 pyramidal
neurons showed that both apical and basal dendrites
remain unaltered in the Ts65Dn model. This fact
indicates that dendritic alteration is not a general feature
of this model and may be limited to specific subtypes of
neurons or to specific regions of the brain.
In a previous report (Hernández-González et al.,
2015), we showed that in the Ts65Dn model there is a
reduction in excitatory contacts (as shown by vesicular
glutamate transporter 1, VGLUT1) and an increment in
inhibitory contacts (using the isoform of 67 KDa of the
glutamate decarboxylase, GAD67). This imbalance
between excitation and inhibition has been observed in
the hippocampus and other brain regions in DS murine
models (Belichenko et al., 2004, 2007, 2009). In this
study we have analysed the expression of the
postsynaptic markers for excitatory contacts (PSD-95)
and for inhibitory contacts (Gephyrin). The results for
gephyrin correlate well with the previously reported
increment for GAD-67 in the Ts65Dn model. However,
regarding the excitatory contacts, with PSD-95 we have
not detected the reduction reported using vGLUT1.
PSD-95 did not change in trisomic mice. Overall, these
results confirm the imbalance between excitation and
inhibition previously observed (Belichenko et al., 2009;
Hernández-González et al., 2015). However, the
discrepancy between the results for VGLUT-1 and PSD-
95 indicates that the number of synapses remains
unaltered but their size may be smaller. Nevertheless, the
efficiency of the excitatory synapses is impaired in the
Ts65Dn model. Some studies reflected an impairment in
LTP in the Ts65Dn model (Kleschevnikov et al., 2004,
2012; Costa and Grybko, 2005), this impairment could
be mediated, at least in part, by this decrease in the
presence of VGLUT-1 in the excitatory synapses.
Decreased expression of BDNF in the hippocampus of
the Ts65Dn model
BDNF is a crucial molecule for the survival and
growth of neurons as well as for the maintenance of their
functional activity. This neurotrophic factor participates
in the stabilization and maturation of synapses during
development as well as in the generation of new synaptic
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contacts during adulthood (for a review see Vicario-
Abejón et al. 2002), inducing the growth of neurites.
Moreover, BDNF has been shown to be necessary for
the generation of neurons during adulthood in the
subgranular zone of the dentate gyrus and in the
subventricular zone (Pinnock and Herbert, 2008). In our
studies, we have observed a general decrease in the
expression of BDNF in the hippocampus of Ts65Dn
mice. Previous studies have reported controversial
results: some studies observed a decrease in mRNA for
BDNF in the whole hippocampus (Bianchi et al., 2010),
whereas others have not observed changes in its
expression (Peng et al., 2009). Studies analysing the
amount of the protein BDNF in the whole hippocampus
have observed reduction (Fukuda et al., 2010) or no
change (Pollonini et al., 2008; Lockrow et al., 2011). In
our study, we have analysed the expression of the protein
using immunohistochemistry and performed a
topographical analysis, using densitometry, in order to
determine in which regions the expression of BDNF is
altered. We observed the reductions affected only some
regions of the dentate gyrus which would have been
missed when analysing the hippocampus as a whole.
The analysis of the expression of BDNF in the
hippocampus of Ts65Dn model has revealed a reduction
in its expression in the stratum moleculare of the dentate
gyrus, where the dendrites of granule cells are located.
This reduction could be related to the dendritic atrophy
observed in granule cells. Moreover, this result may
imply a reduction in the presynaptic inputs that these
neurons receive, as has been already observed in this
model (Belichenko et al., 2009) these projections come
mainly from the entorhinal cortex through the perforant
pathway and are the main source of information that
arrives to the hippocampus. In fact, dendritic atrophy
and impaired synapse formation has been observed in
individuals with DS (Becker et al., 1986). The hilar
region is innervated by granule neuron axons. Adjacent
to the hilar region is located the subgranular zone,
responsible for adult neurogenesis in the hippocampus,
and the reduction observed in BDNF in these areas could
be related to the reduction in neurogenesis observed in
this model (Bianchi et al., 2010; López-Hidalgo et al.,
2016), and in individuals with DS (Wisniewski et al.,
1984). In fact, the knockout mice for BDNF showed a
reduction of 50% in the adult neurogenesis in this area
(Sairanen et al., 2005). BDNF participates in the
processes of generation, survival and differentiation of
the newly generated neurons (Pinnock and Herbert,
2008). The reduction in the expression of BDNF
observed in the stratum lucidum could also be related
with the reduction in the number of newly generated
neurons in the adult hippocampus, since granule cells
project specifically to this stratum of the CA3. The
reduction in BDNF induces a loss in synaptic efficiency
(Alder et al., 2005; Tyler et al., 2006). It has been
observed a reduction in LTP in the slices of the Ts65Dn
mice model (Siarey et al., 1997). The deficit in BDNF
has been related to impairment in hippocampus-
dependent learning and spatial memory (Linnarsson et
al., 1997; Mizuno et al., 2003) and similar alterations
have been observed in individuals with DS (Lott and
Dierssen, 2010) and in Ts65Dn mice (Demas et al.,
1998; Escorihuela et al., 1998).
Decreased expression of PSA-NCAM in the
hippocampus of the Ts65Dn model
The neural cell adhesion molecule (NCAM) is
tightly related to neuronal structural plasticity. This
molecule has the ability to incorporate long chains of the
sugar polysialic acid (PSA), which confers it
antiadhesive properties (Bruses and Rutishauser, 2001).
PSA-NCAM is widely expressed during CNS
development and decreases with age (Varea et al., 2009).
During adulthood, PSA-NCAM is present in brain
regions exhibiting high levels of structural plasticity
such as the olfactory bulb (Miragall et al., 1988), the
hippocampus (Seki and Arai, 1993), the amygdala
(Nacher et al., 2002) and the prefrontal cortex (Varea et
al., 2005). In these regions the presence of PSA is related
to plastic events such as neuronal migration, dendritic
extension or retraction, and synaptogenesis (Seki and
Rutishauser, 1998; Dityatev et al., 2004). Some of these
regions, such as the hippocampus and the olfactory bulb
(Altman and Das, 1965; Altman, 1969; Lois and
Alvarez-Buylla, 1994) retain the ability to incorporate
new neurons. Our results showed a reduction in the
expression of PSA-NCAM in some regions of the
hippocampus in trisomic mice. A decrease in the
expression of PSA-NCAM may induce alterations in
synaptogenesis and neurogenesis. We have observed the
highest decrease in two regions: a) the pyramidal layer
of CA1, in which this reduction could be related to the
reduction of LTP observed in the CA1 region of Ts65Dn
mice (Costa and Grybko, 2005). And b) the hilus and
stratum lucidum, i.e. the regions containing the axons of
granular cells. Reductions of PSA-NCAM expression in
these regions may affect the connectivity between
granule cells and CA3 pyramidal neurons. In fact, the
ablation of PSA from PSA-NCAM in the hippocampus
induces the appearance of aberrant circuits from granule
cells to CA3 pyramidal neurons, and ectopic
synaptogenesis (Seki and Rutishauser, 1998). The
Ts65Dn model displays alterations in this circuit
(Hanson et al., 2007) where there is a reduced number of
thorny excrescences on the principal dendrites of CA3
pyramidal neurons throughout the stratum lucidum
(Stagni et al., 2013).
Increased expression of GAP43 in the hippocampus of
the Ts65Dn model
GAP43 is a protein associated to axonal growth, it is
present in the growth cone, as well as in the synaptic
terminals undergoing active remodelling (Benowitz and
Routtenberg, 1997). During adulthood the expression of
GAP43 is generally low, except in neurons involved in
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synaptic remodelling, such as those in the associative
cortex, the hippocampus and the olfactory bulb
(Oestreicher et al., 1997). GAP43 is a presynaptic
protein, which in mature neurons is located exclusively
in the axons (Gispen et al., 1985; Goslin and Banker,
1990; Goslin et al., 1990). We have observed an
overexpression of GAP43 in the stratum oriens of CA1
(where the axons of pyramidal neurons of CA1 are
located) and in the stratum granulare and hilus of dentate
gyrus (where the axons of granule cells are located).
It has been hypothesized that GAP43 may induce a
reactive synaptogenesis in neurons that have undergone
a reduction in their dendritic complexity (Shapiro and
Whitaker-Azmitia, 2004). Moreover, GAP43 is re-
expressed in neurons with injured axons (Frey et al.,
2000). Therefore, the alterations in synaptogenesis and
dendritogenesis in this model could induce reactive
synaptogenesis as reflected by the overexpression of
GAP43. A possible alternative or complementary
explanation for the increase in GAP43 observed may be
the fact that the expression of GAP43 is, at least in part,
controlled by the kinase Dyrk1A (Guedj et al., 2012), a
gene that is present in three copies in both mice and
humans with DS. Therefore, the overexpression of
Dyrk1A could induce the overexpression of GAP43.
Cooperative interactions
A reduction in PSA-NCAM could be related to the
impaired extension of dendrites observed in the granule
cells of the dentate gyrus in the Ts65Dn mouse model,
producing a strong alteration of hippocampal structure
and more specifically of mossy fibre function, and
consequently of hippocampal information processing. A
deficit in BDNF could be related to the reduction in
neurogenesis and dendritic arbour of granule cells,
therefore affecting hippocampal function. On the
contrary, GAP43 density is increased. This increment
could be related with the deficits observed, among
others, in PSA-NCAM and BDNF, or be directly related
to the extra copy of Dyrk1A. Reactive dendritogenesis
and synaptogenesis (Shapiro and Whitaker-Azmitia,
2004) can be induced by the deficits present in dendritic
and axonal profiles of neurons in the Ts65Dn model.
Alternatively, it has been observed that NCAM and
BDNF signalling converge into GAP43 phosphorylation
(Yoshii and Constantine-Paton, 2007), and this
modification in GAP43 induces its stabilization and
restriction to the axonal and dendritic cone increasing
synaptogenesis. 
Our results have shown significant differences for
different structural plasticity molecules (BDNF, PSA-
NCAM and GAP43) in several regions. Impairment or
reduction in the expression of molecules related to
plasticity induces alterations in cellular migration,
axonal pathfinding, neuritic development, active
remodelling and integration of newly generated neurons;
all these events are present in the Ts65Dn mice. In those
regions in which plasticity markers are affected i.e. the
dentate gyrus, the principal cells show a reduction in
arborisation. On the contrary in those regions in which
plasticity markers are not changed, the morphology of
the principal cells remains unaltered. Treatments with
substances that increases plasticity, like fluoxetine
(Varea et al., 2007a,b; Guirado et al., 2009; Stagni et al.,
2013) have been demonstrated to be able to increase
dendritic arborisation of granule cells (Guidi et al., 2013)
suggesting that lack of plasticity underlies deficiencies
in morphology.
Conclusion
Alterations in dendritic branching correlate with
aberrant expression of molecules related to structural
plasticity, with reduction in BDNF and PSA-NCAM,
and increases of GAP43. Since this only happens in
dentate gyrus, it suggests that impairment in dendritic
arborisation is not a general feature of all Down
Syndrome principal neurons and every type should be
analysed independently. Pharmacological manipulations
of the levels of these molecules could provide a way to
restore granule cell morphology and restore function.
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